ライフサイエンスコーパス: interquartile range

1 ubjects had low hepatic triglycerides (0.5% [interquartile range 0.1%-0.5%]), in contrast to lipodyst

2 Median follow-up was 1.1 (interquartile range 0.4-3.3) years.

3 ntage of time in atrial fibrillation was 0% (interquartile range, 0 to 0.08) with ablation and 0.13%

4 e range, 0 to 0.08) with ablation and 0.13% (interquartile range, 0 to 1.60) with antiarrhythmic drug

5 s (interquartile range, 5 to 78) and 1 hour (interquartile range, 0 to 17), respectively (absolute di

6 utes post-emergency department presentation (interquartile range, 0-109 min), with 83.1% meeting Sequ

7 range, 1-3) than the 4-mm scans (median, 1; interquartile range, 0-3; P = 0.008).

8 The RS had a median value of 0.08 (interquartile range, 0.007-0.71) and a weak and modest c

9 ly lower IgE binding (median ELISA OD, 0.03; interquartile range, 0.01-0.06) than natural Ara h 2 (me

10 During a median follow-up of 0.4 (interquartile range, 0.1-1.4) years, there were 42 (8%)

11 rformed at a median PSA value of 0.60 ng/mL (interquartile range, 0.3-2.4) after a median of 6 mo (in

12 Median PSA was 1.2 ng/mL (interquartile range, 0.6-2.8 ng/mL).

13 etastatic disease at a median of 5.9 months (interquartile range, 0.8-28 months).

14 The median ICU length of stay was 1.57 days (interquartile range, 0.82-2.97 d).

15 than natural Ara h 2 (median ELISA OD, 0.99; interquartile range, 0.90-1.03; P < .01).

16 e epithelium was 1.47 +/- 1.17 (median: 1.5; interquartile range: 0.3-2.4).

17 : 1.05-1.35) and 0.76 +/- 0.49 (median: 0.7; interquartile range: 0.4-1.15) vs. 3.63 +/- 0.29 (median

18 ients with a median PSA level of 0.97 ng/mL (interquartile range: 0.41-2.46 ng/mL) were included.

19 , median intracerebral hemorrhage score 1.5 [interquartile range 1-2], delirium prevalence 57% [n = 3

20 Their median CHA(2)DS(2)-VASc score was 2 (interquartile range 1-3).

21 Studies used a median of 2 instruments (interquartile range 1-4 instruments) and evaluated a med

22 Fluid overload % increased from median (interquartile range) 1.58% (0.23-3.56%; n = 1,017) on da

23 ity kidneys (median Kidney Donor Risk Index (interquartile range) 1.9 (1.0) vs 1.2 (0.7)), there was

24 t delirium with a median duration of 2 days (interquartile range, 1-3 d).

25 days [interquartile range, 2-6 d] vs 2 days [interquartile range, 1-3 d]; p = 0.04).

26 tected on the 2-mm scans (median, 2 lesions; interquartile range, 1-3) than the 4-mm scans (median, 1

27 n, with median time to recovery of 2 months (interquartile range, 1-3), whereas 16 (6.0%) died.

28 luenza-positive hospitalizations was 2 days (interquartile range, 1-4), 18% (95% confidence interval

29 During 2.3 years (interquartile range, 1.0-4.3) follow-up, 160 patients ex

30 days [interquartile range, 4-7 d] vs 3 days [interquartile range, 1.5-5 d]; p < 0.001) and increased

31 The median age at enrollment was 3.2 months (interquartile range, 1.7-5.8 months).

32 During a median follow-up of 2.42 years (interquartile range: 1.04 to 4.29 years), 167 patients d

33 : 3.25-3.55) vs. 1.23 +/- 0.23 (median: 1.2; interquartile range: 1.05-1.35) and 0.76 +/- 0.49 (media

34 patients followed for a median of 2.7 years (interquartile range: 1.3 to 4.4 years), the cumulative i

35 During a median follow-up of 3.6 years (interquartile range: 1.3 to 5.3 years), 830 (16.4%) pati

36 ed <=17 years with a median age of 19 years (interquartile range, 10-32); 423 (52.9%) were males.

37 itive with median ART duration of 41 months (interquartile range, 10-84 months).

38 s [interquartile range, 5 to 7] vs. 13 days [interquartile range, 11 to 14]; absolute difference, 7 d

39 exceeding 96%, with a duration of 27 hours (interquartile range, 11 to 63.5) and 49 hours (interquar

40 ere selected, with a median weight of 18 kg (interquartile range, 11-32).

41 3.0-39.7] uSv in no drape group versus 15.3 [interquartile range, 11.1-20.0] uSv in the drape group;

42 ed endotracheal intubation (n = 12) (median [interquartile range], 11 [8-15] cm H(2)O vs. 31.5 [30-36

43 After a median follow-up time of 696 days (interquartile range 1201 d), survival was significantly

44 Median follow-up was 18 d (interquartile range 13, 30).

45 time to the next exacerbation was 32.5 days (interquartile range 13-50) in the placebo arm and 34 day

46 ain Results: The median MPP deficit was 19% (interquartile range, 13-25), and 54% (interquartile rang

47 en CT acquisition and report was 25 minutes (interquartile range: 13-49 minutes).

48 A median of 39% (interquartile range, 14-72%) of patients had directives

49 Over a median follow-up of 24.5 (interquartile range, 14.8-33.4) months, 52 deaths and 24

50 ata from 782 patients (median age, 59 years [interquartile range, 15 years]) from 54 health care site

51 3 [interquartile range, 221-795] versus 325 [interquartile range, 154-698]; P=0.014).

52 The median number of excised nodes was 21 (interquartile range, 16-27).

53 of spontaneous circulation was 21.1 minutes (interquartile range, 16.1-26.9), and median duration of

54 tibiotic exposure was 41% of inpatient-days (interquartile range, 16.7%-62.5%).

55 ge, 7.6-22.0) and HFOV at the highest (25.7; interquartile range, 16.7-37.3).

56 range 13-50) in the placebo arm and 34 days (interquartile range 17-62) in the ciprofloxacin arm, whi

57 Median follow-up was 21 years (interquartile range 18-24 years).

58 The median age was 36 months (interquartile range, 18-60): 15% were aged between 1-11

59 nilateral PGA exposure time was 31.7 months (interquartile range: 18.8-44.3 months).

60 13.2% during a median follow-up of 632 days (interquartile range: 187 to 1,126 days).

61 s 19% (interquartile range, 13-25), and 54% (interquartile range, 19-82) of time points were spent wi

62 live and out of hospital at 30 days (median [interquartile range], 19 [0- 24] d in both groups; adjus

63 tional Institutes of Health Stroke Scale 4, [interquartile range 2-11]) compared with VKA (6, [2-14])

64 uments) and evaluated a median of 2 domains (interquartile range 2-3 domains).

65 en the two paired assessments was 1.4 years (interquartile range 2.15 years).

66 Median time from transplant was 5.58 y (interquartile range 2.25, 7.33).

67 0.5%]), in contrast to lipodystrophy (10.6% [interquartile range 2.8%-17.1%], P < 0.0001).

68 ian number of ingested substances was three (interquartile range, 2-4); 51.5% were single-substance e

69 asive mechanical ventilation (median 4 days [interquartile range, 2-6 d] vs 2 days [interquartile ran

70 intensity on the numeric rating scale was 4 (interquartile range, 2-6) in the week before survey resp

71 lmonary resuscitation duration was 3.2 days (interquartile range, 2.1-4.9 d).

72 Baseline aBSI (median, 4.5; interquartile range, 2.4-6.5) was moderately correlated

73 recipients at 1 year posttransplant was 10% (interquartile range, 2.7%-19.3%) of baseline weight.

74 nd during the median follow-up of 6.1 years (interquartile range, 2.7-11), 9,776 (4.2%) patients were

75 ring follow-up (median follow-up, 3.1 years; interquartile range, 2.7-3.4 years; range, 0.2-3.8 years

76 erapy patients (median follow-up, 4.2 years [interquartile range, 2.7-6.1]) were analyzed.

77 Over a median follow-up of 6.2 years (interquartile range: 2.7 to 16.5 years), 17 patients exp

78 A total of 57 adults (median age 24 years [interquartile range = 20-29]), 53% of whom were female,

79 The median age was 24 (interquartile range: 20-30) years.

80 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; dat

81 terquartile range, 11 to 63.5) and 49 hours (interquartile range, 22 to 112), respectively (absolute

82 ion of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and

83 ere enrolled; the median age of HHCs was 33 (interquartile range, 22-49) years, and 62% were women.

84 0 persons (51% female; median age, 43 years [interquartile range, 22-62 years]) at the time of the pr

85 reference to directives in a median of 24% (interquartile range, 22-70%).

86 h a median cohort size of 4161 participants (interquartile range, 2204 to 8634 participants).

87 her in black than in nonblack patients (403 [interquartile range, 221-795] versus 325 [interquartile

88 t inclusion criteria, the median Crs was 30 (interquartile range, 23-40) ml/cm H(2)O.

89 n operator radiation dose (median dose 30.5 [interquartile range, 23.0-39.7] uSv in no drape group ve

90 geted temperature management was 32.9 hours (interquartile range, 23.7-37.8).

91 ing follow-up (mean [SD], 358 [384]; median [interquartile range], 232 [10-599] days), BE TAVR was as

92 (10.3) years, 34.4% female, median BMI 26.6 (interquartile range, 24.1-30.1), 46.6% had zero CAC, and

93 ose with P. knowlesi, the median age was 35 (interquartile range: 24-47) years, and 85% were male.

94 edian Eczema Area and Severity Index = 28.3; interquartile range = 25.2-35.3).

95 ery was significantly lower for EVR (median [interquartile range]: $25 924 [$22 280-$32 556] EVR vers

96 brane oxygenation support time was 96 hours (interquartile range, 26-181 hr).

97 During a median follow-up of 40.1 months (interquartile range, 26.5-50.7 months), patients with NA

98 d (51% female, median FEV(1%) predicted, 36 [interquartile range, 27-48]).

99 7 patients (58% female; median age 34 years [interquartile range 28-41]) were ART-eligible at enrollm

100 ) were included (74% females, median age 36 [interquartile range 28-50] years).

101 During a median follow-up of 56 (interquartile range: 28 to 106 months) months, 334 (51%)

102 tissue culture infectious dose/mL was 1780 (interquartile range, 282-8511).

103 artile range, -536 to 153 mL] versus -14 mL [interquartile range, -282 to 335 mL]; P=0.035) and plasm

104 tic AKI-RRT patients, median age 47.6 years (interquartile range: 29.0-64.3) and 76.4% male, were ide

105 a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) w

106 ode to immunotherapy initiation was 5 years (interquartile range, 3-12 years).

107 y numbers for peak shedding were 1.99 x 107 (interquartile range, 3.39 x 106 to 6.37 x 107).

108 workers wearing one badge (median, 6.9 mSv; interquartile range, 3.8213.8 mSv; n = 6218) were simila

109 n and adults was 3.37 +/- 0.34 (median: 3.4; interquartile range: 3.25-3.55) vs. 1.23 +/- 0.23 (media

110 e: 0.4-1.15) vs. 3.63 +/- 0.29 (median: 3.7; interquartile range: 3.45-3.8), respectively.

111 f symptom-onset-to-baseline-CT (hr) (median [interquartile range]: 3 [4] vs 5 [5]; p = 0.468) and fol

112 ation rate (eGFR) was 43.7 ml/min/1.73 m(2) (interquartile range: 30.9 to 60.1 ml/min/1.73 m(2)), and

113 terquartile range 3619) and women (7260 with interquartile range 3068; P=0.52).

114 210 men (62%), with median age of 39 years (interquartile range, 31-45 years).

115 nfatal myocardial infarction over 42 months (interquartile range: 31 to 49 months).

116 ndex scores than their actual donor (median [interquartile range] 31.5 [12.3-47]; P < 0.001 and 26 (-

117 The median central macular ChT was 370 mum (interquartile range 312-406 mum).

118 [interquartile range, 52.6-85.7] versus 41.1[interquartile range, 32.0-78.3]; P=0.047), whereas the d

119 ts (62.3%) within a median time of 103 days (interquartile range: 32 to 392 days).

120 The median age of patients was 50 years (interquartile range 33-63) and 37% were female.

121 42 patients (41%) after a median of 62 days (interquartile range, 33-123 days), a rate higher than th

122 ears (302 [54%] male) (median follow-up, 34 [interquartile range, 33.7-34.7] years).

123 e rate for newer P2Y12 inhibitors was 51.3% (interquartile range, 35.0%-65.9%), with substantial vari

124 step count was similar among men (7202 with interquartile range 3619) and women (7260 with interquar

125 35 mL]; P=0.035) and plasma volume (-138 mL, interquartile range, -379 to 154+/-453 mL; P=0.04).

126 The median gestational age was 39.1 weeks (interquartile range, 38.2-40 wk) and mortality in hospit

127 The median age of cases was 49.5 years (interquartile range 39-59).

128 evaluated using a median of 77 instruments (interquartile range 39-87 instruments).

129 e frequently over time with a median of 58% (interquartile range, 39-89%).

130 3 (34%) by last follow-up (median 63 months; interquartile range: 39 to 87).

131 rquartile range, 588-1563 days] vs 678 days [interquartile range, 392-916 days], respectively; P = .0

132 tile range, 0.3-2.4) after a median of 6 mo (interquartile range, 4-10) after RARP.

133 ntiretroviral therapy for PLHIV was 8 years (interquartile range, 4-10) and 96% were virally suppress

134 from diagnosis to enrollment was 23 months (interquartile range, 4-122), with a median of 3 prior th

135 ciated with longer PICU stay (median 5 days [interquartile range, 4-7 d] vs 3 days [interquartile ran

136 ars, with a median time to LT of 7.5 months [interquartile range, 4.4-10.3].

137 f staff wearing two badges (median, 7.1 mSv; interquartile range, 4.6-11.2 mSv; n = 1449) (P = .18),

138 Median follow-up was 8.0 years (interquartile range: 4.0 to 13.3 years) and 86 (30.2%) p

139 vi [mean fluorescence intensity (MFI), 48.1; interquartile range, 41.7 to 59.6] to primary melanomas

140 ber of cases would have been 67-fold higher (interquartile range 44-94-fold) by 29 February 2020, and

141 ment criteria a median of 118 minutes later (interquartile range, 44-401 min).

142 luated were 156 women (median age, 50 years; interquartile range, 44-63 years).

143 ere enrolled, with a median age of 50 years (interquartile range, 45-55 years); 31% were female, 43%

144 ber of ICU beds needed at the peak by 48.4% (interquartile range 46.4-50.3%), although still exceedin

145 duals on 2DRs were older (median 52.6 years [interquartile range 46.7-59.0] vs 47.7 [39.7-54.3]), and

146 le range, 49-66 years] for DCM and 55 years [interquartile range, 46-62 years] for nonamyloid RCM, P<

147 ed (from 22 sites); their median age was 56 (interquartile range 47-62).

148 l second trimester alpha-T level was 63 muM (interquartile range = 47-82).

149 (duration of combined MCS: median 94 hours; interquartile range, 49-150 hours).

150 st 2013 to July 2015) (median age, 56 years; interquartile range, 49-66 years) and 762 by using DBT (

151 uartile range, 55-69 years] versus 58 years [interquartile range, 49-66 years] for DCM and 55 years [

152 e median door-to-needle time was 65 minutes (interquartile range, 49-88 minutes).

153 rence after a median follow-up of 10 months (interquartile range 5-17).

154 n group, with a median duration of 29 hours (interquartile range, 5 to 78) and 1 hour (interquartile

155 p than in the control group (median, 6 days [interquartile range, 5 to 7] vs. 13 days [interquartile

156 rval since the onset of symptoms was 7 days (interquartile range, 5 to 9).

157 ion before heart transplantation was 9 days (interquartile range, 5-15 d) and median follow-up post h

158 presenting an ACS after a median time of 12 (interquartile range, 5-17) months post-TAVR.

159 k 130 desensitization success was 6.2 years (interquartile range, 5.2-9.1) versus 9.4 years (interqua

160 rs), and the median follow-up was 7.6 years (interquartile range, 5.7-9.9; range, 0.2-19.2).

161 d 950 (93%) completed the follow-up (median [interquartile range], 5.6 [3.6-7.3] years); 117 experien

162 nterquartile range, 69-172 vs 77 procedures, interquartile range, 50-119 in the prior year; standardi

163 st 2015 to July 2017) (median age, 58 years; interquartile range, 50-67 years), (P = .58).

164 PC vs no-CPC (area under the curve), median (interquartile range): 5196 (1823-9061) vs 1934 (831-5301

165 sas City Cardiomyopathy Questionnaire, 68.0 [interquartile range, 52.6-85.7] versus 41.1[interquartil

166 ing in a reduction in blood volume (-208 mL [interquartile range, -536 to 153 mL] versus -14 mL [inte

167 d available ICD codes (median age, 69 years [interquartile range, 54 to 81 years]) and 11.7% had an a

168 otal of 1070 patients (median age, 66 years; interquartile range, 54-75 years; 626 men) were included

169 Biobank (median age at enrollment 63 years, interquartile range 55-72; 38% female; recruitment 2008-

170 2 randomized patients (median age, 60 years [interquartile range, 55-65 years]; 182 men [60.3%]), 283

171 tients with ACM (n=46) were older (61 years [interquartile range, 55-69 years] versus 58 years [inter

172 (25 men and 25 women; median age, 61 years [interquartile range, 56-69 years]; 40 with locally advan

173 were Black, and the median age was 66 years (interquartile range, 56-75 yr).

174 s (17,886, 51%, female; median age 71 years, interquartile range 57-82 years).

175 s The median age of the cohort was 64 years (interquartile range, 57-70 years).

176 At a median follow-up of 68 months (interquartile range, 58-74 months), 157 and 156 DFS even

177 .7 to 59.6] to primary melanomas (MFI, 68.8; interquartile range, 58.4 to 77.0) and metastatic melano

178 n that of invasive adenocarcinoma (939 days [interquartile range, 588-1563 days] vs 678 days [interqu

179 /2016), 284 children (median age 10.7 years, interquartile range 6.7-14.8) were recruited.

180 antibiotic duration in the CRP group was 7 (interquartile range, 6-10; range, 5-28) days; 34 of the

181 st infections appeared at a median age of 8 (interquartile range, 6.0-11.7) months.

182 s and their children (median age, 8.2 years; interquartile range, 6.6-9.1) from the European Human Ea

183 ients (48.7% female, median age of 75 years [interquartile range, 64- 83]).

184 Median follow-up was 108 months, interquartile range 66-136.

185 lume surgeons (median range, 111 procedures; interquartile range, 69-172 vs 77 procedures, interquart

186 Median time to IRIS was 11 days (interquartile range 7-40 days) after antiretroviral ther

187 erquartile range, 5.2-9.1) versus 9.4 years (interquartile range, 7.6-12.8) for failures (P < .001).

188 arted at the lowest oxygenation index (13.0; interquartile range, 7.6-22.0) and HFOV at the highest (

189 f ICU beds is substantially higher at 73.5% (interquartile range 71.4-75.3%).

190 s after importation would be reduced by 76% (interquartile range: 73-77%).

191 study fluid administered on day 1: 1250 mL (interquartile range, 750-2000 mL) in the HES group and 1

192 , 750-2000 mL) in the HES group and 1500 mL (interquartile range, 750-2150 mL) in the saline group (m

193 e were a total of 114,325 cases of COVID-19 (interquartile range 76,776-164,576) in mainland China as

194 o 77.0) and metastatic melanomas (MFI, 87.5; interquartile range, 77.1 to 114.5) (P < 0.001).

195 ian age of 84 years (age range, 51-98 years; interquartile range, 79-88 years) and median follow-up o

196 The median LNR was 20% (interquartile range 9-40).

197 widely across DSAs, with a median of 15.1% (interquartile range [9.3%, 20.9%]; range 0.0%-32.0%).

198 ore the age of 40 months (median, 16 months; interquartile range, 9-29 months).

199 patients, the median MELD-XI score was 10.2 (interquartile range: 9.4 to 13.3); 53 (8%) died and 3 (0

200 system was in the closed-loop mode was 93% (interquartile range, 91 to 95).

201 Among these 69 cases, the median (interquartile range) age was 24 (4.5-196) months, 42 wer

202 Overall, 2,062 patients (62% men, median [interquartile range] age 59 yr [48-67 yr]) were included

203 and at least 1 postbaseline survey (median [interquartile range] age, 64 [59-70] years; 1529 of 1993

204 We studied 347 patients (median [interquartile range] age: 64 yr [53-71 yr] and Acute Phy

205 Variability should be described by S.D. or interquartile range, and precision should be described b

206 Median, interquartile range, and range were calculated for each

207 The median age (interquartile range) at IPD due to serotypes 8 (59 [45-7

208 graphy was delayed by several hours (median [interquartile range] delay = 239 minutes [134-471 min] [

209 The median (interquartile range) duration of follow-up was 1.02 (0.3

210 5-196) months, 42 were male, and the median (interquartile range) duration of hospitalization was 8 (

211 During a median (interquartile range) follow-up of 6.8 (2.5-11.4) years,

212 The median (interquartile range) follow-up time was 4.6 (2.7-7.1) ye

213 Length of stay was reported as median and interquartile range for laparoscopic and robotic: 1.0 da

214 recipients (n = 26) above the upper limit of interquartile range for weight gain at 1 year.

215 The median (interquartile range) for international normalized ratio

216 r the same averaging window of 21 days, each interquartile range increase in daily PM(2.5) was associ

217 lutant model of particle radioactivity, each interquartile range increase in particle radioactivity f

218 ds of a VA event (95% CI, 15%-90%), and each interquartile range increase of particle radioactivity w

219 ED visits for influenza were associated with interquartile range increases in concentrations of GAS (

220 For example, interquartile range increases in PNC within the size ran

221 ons occurred a median of 138 times per case [interquartile range (IQR) 96-190].

222 The odds ratio (OR) per interquartile range (IQR) increase [9,200 particles per

223 imated covariate-adjusted associations of an interquartile range (IQR) increase in log(2)-transformed

224 inter-site MAP variability was 6mmHg with an interquartile range (IQR) of 3 to 9 mmHg.

225 90 women were followed for a median of 24.2 (interquartile range (IQR), 14.2-34.5) months, correspond

226 of voltage was observed (bipolar: 38 cm(2) [interquartile range (IQR), 25-54] versus 53 cm(2) [IQR,

227 le (77% men); age at admission was 47 years [interquartile range (IQR), 40-53 years], age of onset of

228 herosclerosis progression (median: 1 plaque [interquartile range (IQR): -1 to 3 plaques] by 2DVUS; 7.

229 ed in an area under the curve (AUC) of 0.80 (interquartile range (IQR): 0.73-0.86) for discriminating

230 iltration coefficient was lower (calf: 3.30 [interquartile range (IQR): 2.33 to 3.88] l x 100 ml of t

231 infants, median gestational age 26.9 weeks [interquartile range (IQR): 26.3-28.4], median birth weig

232 ine arsenic:creatinine ratio was 7.54 mug/g [interquartile range (IQR): 4.90-11.93] and the cadmium:c

233 ) with a median follow-up time of 5.9 years (interquartile range [IQR] 1.1-14.2).

234 episodes of IC occurred a median of 31 days (interquartile range [IQR] 16-56 days) after transplant,

235 Median age at first booking was 25 years (interquartile range [IQR] 21 to 30), and median parity w

236 CMV DNA (median plasma viral load 498 IU/mL, interquartile range [IQR] 259-2390).

237 age among included children was 4.7 months (interquartile range [IQR] 3-6), 49.5% were female, 23% h

238 ersion was significantly shorter (6.0 weeks, interquartile range [IQR] 4.0-8.3) in the moxifloxacin g

239 al surgery and orbital emphysema was 8 days (interquartile range [IQR] 5-15 days).

240 -OPs, with considerable OPO-level variation (interquartile range [IQR] 54.7%-75.3%; range 0%-100%).

241 equiring a median of 11 doses of eculizumab (interquartile range [IQR] 7-20).

242 cs decreased in the teleID group (median 15, interquartile range [IQR] 9-25), compared to the pre-tel

243 edicted with a median absolute error of 4.8 (interquartile range [IQR] = 1.3-12.8) at 1 week poststro

244 dian time between CT and MRI was 35 minutes (interquartile range [IQR] = 24-50).

245 The median age was 17.0 years (interquartile range [IQR] = 9.0-29.0 years; range = 0-80

246 The median 24-2 VF MD was -6.8 dB (interquartile range [IQR], -4.9 to -12.3 dB).

247 d at least 1 anti-VEGF treatment (median, 4; interquartile range [IQR], 0-12).

248 uration with Spo2 of less than 90%, was 0.7 (interquartile range [IQR], 0.1-5.1) minutes per hour amo

249 n) showed a median viral load of 0.54 cp/ml (interquartile range [IQR], 0.22 to 1.46 cp/ml) and a 14%

250 The median age was 2.8 years (interquartile range [IQR], 1.3 to 5.3); 8.5% (30/353) we

251 ets used for training (median age, 64 years; interquartile range [IQR], 11), 15 for validation (media

252 n CD4 count at diagnosis increased from 326 (interquartile range [IQR], 132-504) cells/uL to 390 (IQR

253 Rvol(FLOW) was higher (median, 24.8 mL; interquartile range [IQR], 14.3-45.7 mL) than Rvol(VALVE

254 eprivation than after normal sleep: (30 min [interquartile range [IQR], 17-41] vs. 60 min [IQR, 45-60

255 harge to last recorded follow-up of 30 days (interquartile range [IQR], 17-46 days).

256 group, median filter life span was 47 hours (interquartile range [IQR], 19-70 hours) vs 26 hours (IQR

257 ative score categories (1+ to 4+) were 1:10 (interquartile range [IQR], 1:5 to 1:20) in the CrAgSQ 1+

258 The median age of patients was 53 years (interquartile range [IQR], 33-69 years) and 100 (48.3%)

259 ived among patients on bedaquiline-based (4; interquartile range [IQR], 4-4) and delamanid-based (4;

260 The median baseline VA was 60 (interquartile range [IQR], 45-70) letters, which improve

261 Diabetic Retinopathy Study (ETDRS) letters (interquartile range [IQR], 5.0-20.0) from 65.0 (IQR, 58.

262 The median age was 60 years old (interquartile range [IQR], 54, 66), and 23% were African

263 with DM (both groups: median age, 59 years; interquartile range [IQR], 54-64 years).

264 tively, over median follow-up of 15.5 years (interquartile range [IQR], 6.3 years) and 14.2 (IQR, 2.5

265 at presentation of 35 children was 26 days (interquartile range [IQR], 7-106 days).

266 verall, patients were followed for a median (interquartile range [IQR], range) of 49.5 (15.3, 7.0-66.

267 stomach, kidneys, and bone marrow were 0.88 (interquartile range [IQR]: 0.85-1.04), 0.42 (IQR: 0.25-1

268 alized in 62 patients (75%) within 3 months (interquartile range [IQR]: 1.5 to 6 months) of anticoagu

269 nducted in 1,023 patients-very early, 2.5 h (interquartile range [IQR]: 1.8 to 4.2 h), n = 583; and s

270 nderwent TPVR at a median age of 18.3 years (interquartile range [IQR]: 12.9 to 27.3 years) and weigh

271 ary veins [PVs]; mean ablation time: 22 min; interquartile range [IQR]: 15 to 29 min) and LAPW ablati

272 dialysis facilities in Network 6 was 33.7% (interquartile range [IQR]: 25.3%-43.1%).

273 were males; median procedure times were 50 (interquartile range [IQR]: 38-71) and 60(IQR: 48-77) min

274 end-stage liver disease score at LT was 7 ((interquartile range [IQR]: 6-11) and waiting time 78.5 d

275 notyped cohort of 893 PCOS cases (median and interquartile range [IQR]: age = 28 [25-32], body mass i

276 linical presentations (median Pitt score, 0 [interquartile range {IQR} 0-1] vs 1 [IQR 0-2] in patient

277 d significantly lower median h-indices (4.0 [interquartile range {IQR} 7.0] vs 11.0 [IQR 17.0], P < .

278 -low group than the sero-high group (9 days [interquartile range {IQR} 7.5-11.0] vs 11.0 days [IQR 7.

279 in younger children (median age, 1.7 years [interquartile range {IQR}, 0.1-6.9]) compared with immun

280 isolates was similar to that of NL4.3 (1.01 [interquartile range {IQR}, 0.86 to 1.18]), while the med

281 FeNO than uninfected controls (median, 17.0 [interquartile range {IQR}, 11.0-26.0] vs 13.0 [IQR, 9.0-

282 cohort, 162 patients [median age, 29 years; interquartile range {IQR}, 24-36 years; 84 men]) were us

283 Fifty-eight children (median age, 9 years [interquartile range {IQR}, 5.7-14]; 20 girls [34%]) were

284 9 (99%) completed the trial (median age, 66 [interquartile range {IQR}, 56-74] years; 246 [36%] women

285 ngth of stay was shorter (control: 30 hours [interquartile range {IQR}, 6-122] vs diversion: 22 [IQR,

286 Of the 203 participants (median age, 68 [interquartile range {IQR}, 65-71] years; median type 1 d

287 P = 0.03) and more publications [median 70 (interquartile range, IQR 55-100) vs 40 (IQR 22-67), P =

288 patients with HFrEF (65+/-11 years, median [interquartile range] left ventricular ejection fraction

289 edian follow-up time was 7.4 months, with an interquartile range of 3.3 to 13.1 months (standard devi

290 rmalized to the whole lung mean (FV(N)), and interquartile range of normalized ventilation (IQR(N); a

291 54.3% women) were followed up for a median (interquartile range) of 8.9 (8.3-9.5) years.

292 The median (interquartile range) of APRI (n = 106), FIB-4 (n = 106),

293 perative days [area under the curve: median (interquartile range) pg/mL: 3285 (1697-6179) vs 1290 (75

294 t baseline of 76.60+/-6.65 years and median (interquartile range) review period of 1.17 years (1.01-1

295 Median (interquartile range) steady-state trough TFV concentrati

296 The median (interquartile range) time from KPD entry to transplantat

297 Median (interquartile range) TTR were 37.0 h (21.8 to 51.7 h) an

298 nterindividual variability and lower median (interquartile range) values for sTXB2 (ng/mL) compared w

299 uals, median most diseased segment TBR(max) (interquartile range) was higher in culprit than in noncu

300 Time to electroencephalography (median [interquartile range]) was 5 minutes (4-10 min) with rapi